FAB-144

FAB-144 is a type of synthetic cannabinoid, which is a group of chemical compounds that mimic the effects of cannabinoids naturally produced by the cannabis plant. FAB-144 was first identified in Japan in 2013, and it is sold as a designer drug.

Chemistry

FAB-144 is a derivative of indazole, a type of organic compound. It is specifically an indazole-3-carboxamide, which means it has a carboxamide group attached to the third carbon atom of the indazole ring. The full chemical name of FAB-144 is N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide.

Effects

The effects of FAB-144 are similar to those of other synthetic cannabinoids and can include euphoria, relaxation, and altered perception. However, because it is a research chemical, the full range of its effects is not well understood. It is known to be a potent agonist of the CB1 receptor, which is found in the brain and is responsible for the psychoactive effects of cannabis.

Legal status

FAB-144 is illegal in many countries, including the United States, where it is classified as a Schedule I drug under the Controlled Substances Act. It is also banned in many European countries under the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).

Health risks

As with other synthetic cannabinoids, FAB-144 can have serious health risks. These can include psychosis, seizures, and even death. Because it is often sold as a legal alternative to cannabis, users may not be aware of these risks.

See also

• Synthetic cannabinoids
• Indazole
• Cannabinoids
• Cannabis
• Designer drug
• CB1 receptor
• Controlled Substances Act
• European Monitoring Centre for Drugs and Drug Addiction

• 
  FAB-144